NYSE:CRL Charles River Laboratories International Q3 2026 Earnings Date & Estimates $297.64 -2.66 (-0.89%) Closing price 10/8/2026 03:59 PM EasternExtended Trading$301.00 +3.36 (+1.13%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Charles River Laboratories International is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens. The conference call is scheduled for 9:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeBefore Market OpensConference Call9:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Charles River Laboratories International in Q3 2026Charles River Laboratories International is expected to post earnings of $2.97 per share on revenue of $959.99 million. In the same quarter a year earlier Charles River Laboratories International reported $2.43 per share on revenue of $1.00 billion. Charles River Laboratories International last reported on August 5, 2026, posting $3.02 per share and beating the $2.77 consensus estimate. Charles River Laboratories International has beaten the consensus EPS estimate in 8 of its last 8 quarters.Consensus EstimatesConsensus EPS$2.97Expected Revenue$959.99 millionPrior-Year EPS$2.43Prior-Year Revenue$1.00 billionExpected EPS Growth+22.2%Expected Revenue Growth-4.5%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$3.02 (Beat by +$0.25)Last Quarter Revenue$1.00 billionEPS Beat Rate8 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Charles River Laboratories International Q3 2026 Earnings FAQ When does Charles River Laboratories International report Q3 2026 earnings? Charles River Laboratories International (NYSE:CRL) is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, before market opens. What time is Charles River Laboratories International's Q3 2026 earnings call? Charles River Laboratories International's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 9:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Charles River Laboratories International? Analysts expect Charles River Laboratories International to post earnings of $2.97 per share for Q3 2026. How much revenue is Charles River Laboratories International expected to report? The consensus revenue estimate for Charles River Laboratories International is $959.99 million for Q3 2026. Charles River Laboratories International Earnings HeadlinesZacks Research Issues Optimistic Forecast for CRL EarningsOctober 7 at 8:17 AM | americanbankingnews.comCharles River and Autolomous Partner to Transform Laboratory Execution SystemsOctober 6 at 12:33 PM | marketscreener.comMThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.October 9 at 1:00 AM | Investors Alley (Ad)Charles River Laboratories International, Inc. and Autolomous Launch Apollo Orchestrate Within Charles River's Apollo PlatformOctober 6 at 12:33 PM | marketscreener.comMCharles River Labs and Autolomous launch Apollo Orchestrate for digital lab executionOctober 6 at 12:33 PM | msn.comResearch Analysts Offer Predictions for CRL FY2026 EarningsOctober 6 at 6:12 AM | americanbankingnews.comSee More Charles River Laboratories International Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Charles River Laboratories International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Charles River Laboratories International and other key companies, straight to your email. Email Address About Charles River Laboratories InternationalCharles River Laboratories International (NYSE:CRL) is a contract research organization that provides products and services to support pharmaceutical, biotechnology and academic research. The company helps customers discover, develop and manufacture new medicines, vaccines and other healthcare products. Its offerings include research models and related services, preclinical drug discovery, pharmacology, toxicology, bioanalysis and safety assessment. Charles River also provides laboratory and manufacturing solutions for biologics, cell and gene therapies, microbial testing and other specialized life sciences applications. Founded in 1947, Charles River Laboratories serves customers worldwide through operations across North America, Europe and Asia. The company is headquartered in Wilmington, Massachusetts, and its common stock trades on the New York Stock Exchange under the symbol CRL. James C. Foster has served as the company's chairman and chief executive officer for many years.View Charles River Laboratories International ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Applied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueSkydance Just Became a Media Giant—With an $80 Billion Debt LoadConstellation Brands Beat Earnings, But Beer Demand Is Still a ProblemTesla's EV Delivery Beat Is In, So What Happens Now?BigBear.ai Is Heavily Shorted—and Its Fundamentals Are Starting to Change Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
